<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Hypertension (Dr. Karari)</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="cardiology-infective-endocarditis-4a.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 34.6%;"></div> <!-- Set percentage dynamically with static value for this chunk -->
                        </div>
                       <span class="progress-text">Lecture 18 of 52</span> <!-- Update text with static value for this chunk -->
                    </div>
                    <a href="cardiology-hypertensive-emergencies.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">HYPERTENSION</h1>
                <p>Dr. Emma M. Karari Cardiologist/ Lecturer UON - Dept. of Medicine</p>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                <!-- START: intro -->
                <section id="intro" class="content-section" aria-labelledby="section-heading-1">
                    <h2 id="section-heading-1" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">INTRODUCTION</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>CVD is currently a world wide epidemic</li>
                            <li>Hypertension is a key CVD risk factor</li>
                            <li>The communicable diseases epidemic is not yet under control in our country</li>
                            <li>We do not have the resources to handle two epidemics</li>
                            <li>We need to act quickly to prevent CVD and treat those already affected</li>
                        </ul>
                    </div>
                </section>
                <!-- END: intro -->

                <!-- START: definition -->
                <section id="definition" class="content-section" aria-labelledby="section-heading-2">
                    <h3 id="section-heading-2" class="subsection-heading">Hypertension: definition</h3>
                    <div class="content-card">
                        <ul>
                            <li>BP >/= 140/90 is considered as defining term, but hypertension is a continuum</li>
                            <li>Cardiovascular risk doubles with every 20/10mmhg rise BP from 115/75mmhg between age 40 to 70 yrs</li>
                            <li>Isolated systolic/diastolic hypertension should be treated like any other hypertension, higher figure determines grade</li>
                            <li>White coat hypertension is also associated with increased cardiovascular risk</li>
                            <li>It is an asymptomatic lifelong disease requiring life long treatment</li>
                            <li>Progressive cardiovascular syndrome associated with target organ damage</li>
                            <li>It's assoc with increased risk for stroke, coronary artery disease, heart failure, renal failure, retinopathy and peripheral vascular disease.</li>
                            <li>Treatment results in reduction in these complications</li>
                            <li>Major challenges exist in diagnosis and treatment</li>
                        </ul>
                    </div>
                </section>
                <!-- END: definition -->

                <!-- START: bp-classification -->
                <section id="bp-classification" class="content-section" aria-labelledby="section-heading-3">
                    <h3 id="section-heading-3" class="subsection-heading">BP CLASSIFICATION</h3>
                    <div class="table-container">
                        <table class="content-table">
                            <thead>
                                <tr>
                                    <th>ESH-ESC category (1)</th>
                                    <th>Systolic BP mmHg</th>
                                    <th>Diastolic BP mmHg</th>
                                    <th>JNC-7 category (2)</th>
                                </tr>
                            </thead>
                            <tbody>
                                <tr>
                                    <td>Optimal</td>
                                    <td><120</td>
                                    <td><80</td>
                                    <td>Normal</td>
                                </tr>
                                <tr>
                                    <td>Normal</td>
                                    <td>120-129</td>
                                    <td>80-84</td>
                                    <td rowspan="2">Pre hypertension</td>
                                </tr>
                                <tr>
                                    <td>High normal</td>
                                    <td>130-139</td>
                                    <td>85-89</td>
                                </tr>
                                <tr>
                                    <td>Grade 1 hypertension (mild)</td>
                                    <td>140-159</td>
                                    <td>90-99</td>
                                    <td>Stage 1 hypertension</td>
                                </tr>
                                <tr>
                                    <td>Grade 2 hypertension (moderate)</td>
                                    <td>160-179</td>
                                    <td>100-109</td>
                                    <td rowspan="2">Stage 2 hypertension</td>
                                </tr>
                                <tr>
                                    <td>Grade 3 hypertension (severe)</td>
                                    <td>180</td>
                                    <td>110</td>
                                </tr>
                            </tbody>
                        </table>
                    </div>
                </section>
                <!-- END: bp-classification -->

                <!-- START: epidemiology -->
                <section id="epidemiology" class="content-section" aria-labelledby="section-heading-4">
                    <h2 id="section-heading-4" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">EPIDEMIOLOGY</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Global Burden of Hypertension: Analysis of Worldwide Data</h3>
                        <p>In 2000, 26.4% (95% CI 26.0-26.8%) of the adult population had hypertension, 26.6% of men & 26.1% of women.</p>
                        <ul>
                            <li>By 2025, 29.2% (28.8-9.7%) were projected to be hypertensive, 29.0% of men & 29.5% of women.</li>
                            <li>In 2000, 972 million adults had hypertension; 333 million (329-336 million) in economically developed countries & 639 million (625-654 million) in economically developing countries.</li>
                            <li>By 2025, the number of adults with hypertension was predicted to increase by about 60% to a total of 1.56 billion.</li>
                        </ul>
                        <h3 class="subsection-heading">Global Burden of Hypertension: Africa</h3>
                        <ul>
                            <li>In Tanzania, > above 37% in an urban area and more than 26% in a rural population</li>
                            <li>Kenya -rural - 33%</li>
                            <li>Of all patients with hypertension in Africa, only 1/3 are aware.</li>
                            <li>Of those diagnosed only 1/3 are on treatment</li>
                            <li>Of those on treatment only 1/3 are controlled</li>
                        </ul>
                    </div>
                </section>
                <!-- END: epidemiology -->

                <!-- START: pathophysiology -->
                <section id="pathophysiology" class="content-section" aria-labelledby="section-heading-5">
                    <h2 id="section-heading-5" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">PATHOPHYSIOLOGY</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Control of blood pressure</h3>
                        <figure>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-11-1.jpg" alt="Diagram showing factors that control blood pressure, including cardiac output and peripheral vascular resistance." class="content-image">
                        </figure>
                        <h3 class="subsection-heading">Multifactorial origin of Hypertension</h3>
                        <figure>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-12-1.jpg" alt="Flowchart illustrating the multifactorial origin of hypertension, involving genetic and environmental factors leading to increased cardiac output or peripheral vascular resistance." class="content-image">
                        </figure>
                        <p>vascular resistance (PVR), as seen in elderly patients.</p>
                        <figure>
                            <figcaption>Important Recognized Causes of Secondary Hypertension</figcaption>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-13-1.jpg" alt="Table listing common and less common causes of secondary hypertension." class="content-image">
                        </figure>
                        <figure>
                            <figcaption>Associated Conditions Increase CVD Risk</figcaption>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-14-1.jpg" alt="List of conditions associated with increased cardiovascular disease risk." class="content-image">
                        </figure>
                        <p>The high prevalence of hypertension worldwide has contributed to the present pandemic of cardiovascular diseases (CVD) - responsible for 30% of all deaths worldwide</p>
                        <h3 class="subsection-heading">The cardiovascular continuum</h3>
                        <figure>
                            <figcaption>Role of AT II and SNS</figcaption>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-15-1.jpg" alt="Diagram of the cardiovascular continuum, showing the progression from risk factors to end-stage heart disease and the roles of Angiotensin II and the Sympathetic Nervous System." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: pathophysiology -->

                <!-- START: diagnosis -->
                <section id="diagnosis" class="content-section" aria-labelledby="section-heading-6">
                    <h2 id="section-heading-6" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">DIAGNOSIS</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Diagnosis of Arterial Hypertension</h3>
                        <p><strong>Symptoms</strong></p>
                        <ul>
                            <li>Most patients are asymptomatic</li>
                            <li>Diagnosis at routine medical examination</li>
                            <li>Diagnosis when stroke or MI</li>
                            <li>Hypertension called "Silent Killer"</li>
                        </ul>
                        <p><strong>Diagnostic procedures</strong></p>
                        <p>Aim:</p>
                        <ul>
                            <li>Establishing blood pressure levels</li>
                            <li>Identifying secondary causes of hypertension</li>
                            <li>Evaluating the overall cardiovascular risk</li>
                        </ul>
                        <p>Procedures:</p>
                        <ul>
                            <li>Repeated blood pressure measurements</li>
                            <li>Medical history</li>
                            <li>Physical examination</li>
                            <li>Laboratory and instrumental investigations</li>
                        </ul>
                        <h3 class="subsection-heading">BP measurement</h3>
                        <ul>
                            <li>Patient sits for 5 mins -back supported, arm supported at the level of the heart</li>
                            <li>No caffeine/adrenergic stimulants</li>
                            <li>No smoking in the preceding 15 mins</li>
                            <li>Cuff should encircle and cover two thirds of the length of the arm</li>
                            <li>Use a mercury sphygmomanometer or validated electronic BP machine</li>
                            <li>Two recordings at each visit at least three sets of readings one week apart</li>
                            <li>Deflate at 2 mm/hg/second</li>
                            <li>Record Korotkoff sound I -SBP V - DBP</li>
                        </ul>
                        <h3 class="subsection-heading">Diagnosis of Arterial Hypertension</h3>
                        <p>Medical history with particular attention to:</p>
                        <ul>
                            <li>Hypertension</li>
                            <li>Life style factors - smoking, alcohol, diet, physical exercise, family history etc</li>
                            <li>Diabetes</li>
                            <li>Dyslipidemia</li>
                            <li>Premature coronary heart disease</li>
                            <li>Stroke</li>
                            <li>Renal disease</li>
                        </ul>
                        <p>Physical examination</p>
                        <ul>
                            <li>Signs suggesting secondary hypertension obesity height, weight, BMI, WC, HC, HWR</li>
                            <li>Signs of organ damage: Brain, Retina</li>
                        </ul>
                        <h3 class="subsection-heading">Laboratory and instrumental investigations</h3>
                        <p><strong>Routine tests</strong></p>
                        <ul>
                            <li>Plasma glucose</li>
                            <li>Total cholesterol, HDL-cholesterol, fasting serum triglycerides</li>
                            <li>Serum creatinine, uric acid</li>
                            <li>Serum potassium</li>
                            <li>Hemoglobin and hematocrit</li>
                            <li>Urinalysis (dipstick, urinary sediment)</li>
                            <li>Electrocardiogram</li>
                        </ul>
                        <p><strong>Recommended tests</strong></p>
                        <ul>
                            <li>Echocardiogram, Carotid ultrasound</li>
                            <li>Postprandial plasma glucose (if FBS > 6.1 mmol /l or 110 mg/l)</li>
                            <li>C-reactive protein (high sensitivity)</li>
                            <li>Microalbuminuria (essential in diabetics)</li>
                            <li>24 hr proteinuria (if dipstick positive)</li>
                            <li>Funduscopy (in severe hypertension)</li>
                        </ul>
                        <h3 class="subsection-heading">Factors influencing prognosis</h3>
                        <p>Risk factors for cardiovascular disease used for stratification</p>
                        <ul>
                            <li>Levels of systolic and diastolic BP</li>
                            <li>Men > 55 years; Women > 65 years</li>
                            <li>Smoking</li>
                            <li>Dyslipidemia</li>
                            <li>Family history of PCAD</li>
                            <li>Abdominal obesity (circ) M>102 cm, W > 88 cm )</li>
                            <li>C-reactive protein >1 mg/dl</li>
                            <li>Diabetes mellitus
                                <ul>
                                    <li>Fasting plasma glucose > 7.0 mmol/l</li>
                                    <li>Postprandial plasma glucose > 11.0 mmol/l</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                <!-- END: diagnosis -->

                <!-- START: prognosis-factors -->
                <section id="prognosis-factors" class="content-section" aria-labelledby="section-heading-7">
                    <h2 id="section-heading-7" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Factors influencing prognosis</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Target organ damage (TOD)</h3>
                        <ul>
                            <li>LVH (ECG/ echo)</li>
                            <li>Carotid arterial wall thickening or atherosclerotic plaque (US)</li>
                            <li>Slight increase in serum creatinine (M 115-133, W 107-124 µmol/I)</li>
                            <li>Microalbuminuria (30-300 mg/24h; albumin-creatinine ratio M > 2.5, W > 3.5</li>
                            <li>Cardiovascular disease; CVA/TIA</li>
                            <li>Heart disease: AMI, angina, CABG, CHF</li>
                            <li>Renal disease: diabetic nephropathy</li>
                            <li>Peripheral vascular disease</li>
                            <li>Advanced retinopathy: haemorrhages or exudates, papilloedema</li>
                        </ul>
                        <h3 class="subsection-heading">Cardiovascular Risk Stratification to Quantify Prognosis</h3>
                        <div class="table-container">
                            <table class="content-table">
                                <thead>
                                    <tr>
                                        <th></th>
                                        <th>Normal<br>SBP 120-129 or<br>DBP 80-84</th>
                                        <th>High normal<br>SBP 130-139 or<br>DBP 85-89</th>
                                        <th>Grade 1<br>SBP 140-159 or<br>DBP 90-99</th>
                                        <th>Grade 2<br>SBP 160-179 or<br>DBP 100-109</th>
                                        <th>Grade 3<br>SBP ≥ 180 or<br>DBP ≥ 110</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>No other Risk Factors (RF)</strong></td>
                                        <td>Average risk</td>
                                        <td>Average risk</td>
                                        <td>Low added risk</td>
                                        <td>Moderate added risk</td>
                                        <td>High added risk</td>
                                    </tr>
                                    <tr>
                                        <td><strong>1 or 2 Additional RF</strong></td>
                                        <td>Low added risk</td>
                                        <td>Low added risk</td>
                                        <td>Moderate added risk</td>
                                        <td>Moderate added risk</td>
                                        <td>Very high added risk</td>
                                    </tr>
                                    <tr>
                                        <td><strong>3 or more RF, or Met synd or TOD</strong></td>
                                        <td>Moderate added risk</td>
                                        <td>High added risk</td>
                                        <td>High added risk</td>
                                        <td>High added risk</td>
                                        <td>Very high added risk</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Established CV or Renal disease</strong></td>
                                        <td>High added risk</td>
                                        <td>Very high added risk</td>
                                        <td>Very high added risk</td>
                                        <td>Very high added risk</td>
                                        <td>Very high added risk</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <p>Absolute added 10 year risk of cardiovascular disease (Framingham): <br> <15% (Low), 15-20% (Moderate), 20-30% (High), >30% (Very High)</p>
                        <p>TOD = Target Organ Damage</p>
                    </div>
                </section>
                <!-- END: prognosis-factors -->

                <!-- START: treatment -->
                <section id="treatment" class="content-section" aria-labelledby="section-heading-8">
                    <h2 id="section-heading-8" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">TREATMENT</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Effective Blood Pressure Control Reduces Cardiovascular Morbidity and Mortality</h3>
                        <figure>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-26-1.jpg" alt="Bar chart showing the percentage reduction in stroke, coronary heart disease, and cardiovascular death with effective blood pressure control." class="content-image">
                            <figcaption>Event reduction in patients on active antihypertensive treatment versus placebo or no treatment. CHD: coronary heart disease; CV: cardiovascular</figcaption>
                        </figure>
                        <h3 class="subsection-heading">BP Reductions as Little as 2 mm Hg Reduce Risk of CV Events by Up to 10%</h3>
                        <p>Meta-analysis of 61 prospective, observational studies</p>
                        <figure>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-27-1.jpg" alt="Chart showing that a 2 mm Hg reduction in systolic blood pressure reduces the risk of stroke and ischemic heart disease." class="content-image">
                        </figure>
                        <h3 class="subsection-heading">Natural History of Cardiovascular Disease</h3>
                        <figure>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-28-1.jpg" alt="Flowchart illustrating the natural history of cardiovascular disease from risk factors to organ damage and death." class="content-image">
                        </figure>
                        <h3 class="subsection-heading">Goals of Treatment</h3>
                        <ul>
                            <li>Maximum decrease in long-term total CV risk</li>
                            <li>Lower level of systolic and diastolic BP per se</li>
                            <li>Treat all reversible risk factors and associated conditions</li>
                            <li>Target BP:
                                <ul>
                                    <li>At least <140/90 mmHg in all HT patients</li>
                                    <li><130/80 mmHg in diabetics and other high risk patients eg renal dysfunction, CVA, proteinuria, post AMI</li>
                                </ul>
                            </li>
                            <li>Difficult to achieve in the elderly</li>
                            <li>Start anti hypertensive before cardiovascular complications develop</li>
                        </ul>
                        <h3 class="subsection-heading">Lifestyle Changes</h3>
                        <p>Purpose: lower BP, control other risk factors, reduce number of drugs required to reach target</p>
                        <ul>
                            <li>This is for all and should be normal way of life in all to prevent hypertension</li>
                            <li>Smoking cessation</li>
                            <li>Weight reduction</li>
                            <li>Reduction of excessive alcohol intake</li>
                            <li>Physical exercise</li>
                            <li>Reduction of salt intake</li>
                            <li>Increase in fruit and vegetable intake</li>
                            <li>Decrease in saturated and total fat intake</li>
                        </ul>
                    </div>
                </section>
                <!-- END: treatment -->

                <!-- START: treatment-initiation -->
                <section id="treatment-initiation" class="content-section" aria-labelledby="section-heading-9">
                    <h2 id="section-heading-9" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Initiation of antihypertensive treatment</span>
                    </h2>
                    <div class="content-card">
                        <div class="table-container">
                            <table class="content-table">
                                <caption>Blood pressure (mmHg)</caption>
                                <thead>
                                    <tr>
                                        <th>Other risk factors and disease history</th>
                                        <th>Normal<br>SBP 120-129 or DBP 80-84</th>
                                        <th>High normal<br>SBP 130-139 or DBP 85-89</th>
                                        <th>Grade 1<br>SBP 140-159 or DBP 90-99</th>
                                        <th>Grade 2<br>SBP 160-179 or DBP 100-109</th>
                                        <th>Grade 3<br>SBP ≥ 180 or DBP ≥ 110</th>
                                    </tr>
                                </thead>
                                <tbody>
                                    <tr>
                                        <td><strong>No other Risk Factors (RF)</strong></td>
                                        <td>No BP intervention</td>
                                        <td>No BP intervention</td>
                                        <td>Lifestyle changes for several months, then drug treatment</td>
                                        <td>Lifestyle changes for several wks then drug treatment</td>
                                        <td>Immediate drug treatment and lifestyle changes</td>
                                    </tr>
                                    <tr>
                                        <td><strong>1-2 Additional RF</strong></td>
                                        <td>Lifestyle changes</td>
                                        <td>Lifestyle changes</td>
                                        <td>Lifestyle changes for several wks then drug treatment</td>
                                        <td>Lifestyle changes for several wks, then drug treatment</td>
                                        <td>Immediate drug treatment and lifestyle changes</td>
                                    </tr>
                                    <tr>
                                        <td><strong>3 or more RF, or Diabetes or TOD</strong></td>
                                        <td>Lifestyle changes + drug treatment if DM</td>
                                        <td>Drug treatment and lifestyle changes</td>
                                        <td>Drug treatment and lifestyle changes</td>
                                        <td>Drug treatment and lifestyle changes</td>
                                        <td>Immediate drug treatment and lifestyle changes</td>
                                    </tr>
                                    <tr>
                                        <td><strong>Established CV or Renal disease</strong></td>
                                        <td>Drug treatment and lifestyle changes</td>
                                        <td>Immediate drug treatment and lifestyle changes</td>
                                        <td>immediate drug treatment and lifestyle chances</td>
                                        <td>Immediate drug treatment and lifestyle chances</td>
                                        <td>Immediate drug treatment and lifestyle changes</td>
                                    </tr>
                                </tbody>
                            </table>
                        </div>
                        <p><small>TOD, target organ damage; SBP, systolic blood pressure; DBP, diastolic blood pressure.</small></p>
                    </div>
                </section>
                <!-- END: treatment-initiation -->
                
                <!-- START: pharma-treatment -->
                <section id="pharma-treatment" class="content-section" aria-labelledby="section-heading-10">
                    <h2 id="section-heading-10" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Algorithm for Pharmacological Treatment of Hypertension</span>
                    </h2>
                    <div class="content-card">
                        <p>Consider:</p>
                        <ul>
                            <li>Blood pressure level before treatment</li>
                            <li>Absence or presence of TOD and risk factors</li>
                        </ul>
                        <p>Choose between:</p>
                        <figure>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-32-1.jpg" alt="Algorithm for the pharmacological treatment of hypertension, showing different drug classes and combination options." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: pharma-treatment -->

                <!-- START: jnc7-recommendations -->
                <section id="jnc7-recommendations" class="content-section" aria-labelledby="section-heading-11">
                    <h2 id="section-heading-11" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Recommendations by ADA, ISHIB, and NKF consistent with JNC 7</span>
                    </h2>
                    <div class="content-card">
                        <p>Drug therapy is recommended for all patients with hypertension (SBP/DBP >140/90 mmHg)</p>
                        <ul>
                            <li>BP goals
                                <ul>
                                    <li><140/90 mmHg</li>
                                    <li><130/80 mmHg for patients with diabetes mellitus</li>
                                    <li><125/75 mmHg CRF + proteinuria >1 g/day</li>
                                </ul>
                            </li>
                            <li>Multiple drug therapy with 2 or more agents at adequate doses (thiazide diuretic, ACE inhibitor, ARB, beta-blocker, CCB) is usually required to achieve BP targets</li>
                            <li>ISHIB guidelines: consider initiating treatment with 2 drugs if BP is ≥ 15/10 mmHg above goal</li>
                        </ul>
                    </div>
                </section>
                <!-- END: jnc7-recommendations -->

                <!-- START: compelling-indications -->
                <section id="compelling-indications" class="content-section" aria-labelledby="section-heading-12">
                    <h2 id="section-heading-12" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Compelling drug indications</span>
                    </h2>
                    <div class="content-card">
                        <p>In case of Sub clinical organ damage</p>
                        <ul>
                            <li>LVH - ARB, ACE, CCB</li>
                            <li>Microalbuminuria/ renal dysfunction - ARB, ACE</li>
                            <li>Heart failure - ACE, BB, ARB, diuretics, aldosterone inhibitors</li>
                            <li>Metabolic syndrome - ARB, ACE, CCB</li>
                            <li>ISH (elderly) - diuretics, CCB</li>
                            <li>Pregnancy - BB, CCB, alpha methyldopa</li>
                        </ul>
                    </div>
                </section>
                <!-- END: compelling-indications -->

                <!-- START: recommended-combinations -->
                <section id="recommended-combinations" class="content-section" aria-labelledby="section-heading-13">
                    <h2 id="section-heading-13" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Recommended combinations</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li><strong>Thiazide diuretics</strong> combine well with:
                                <ul>
                                    <li>ACE inhibitors (favorable)</li>
                                    <li>ARBs (favorable)</li>
                                    <li>Beta-blockers</li>
                                    <li>Calcium antagonists</li>
                                </ul>
                            </li>
                            <li><strong>Calcium antagonists</strong> combine well with:
                                <ul>
                                    <li>Thiazide diuretics (favorable)</li>
                                    <li>ACE inhibitors (favorable)</li>
                                    <li>ARBs (favorable)</li>
                                    <li>Beta-blockers (less recommended)</li>
                                </ul>
                            </li>
                            <li><strong>ACE inhibitors</strong> combine well with:
                                <ul>
                                    <li>Thiazide diuretics (favorable)</li>
                                    <li>Calcium antagonists (favorable)</li>
                                    <li>Beta-blockers (less recommended)</li>
                                    <li>ARBs (not recommended)</li>
                                </ul>
                            </li>
                            <li><strong>ARBs</strong> combine well with:
                                <ul>
                                    <li>Thiazide diuretics (favorable)</li>
                                    <li>Calcium antagonists (favorable)</li>
                                    <li>Beta-blockers (less recommended)</li>
                                    <li>ACE inhibitors (not recommended)</li>
                                </ul>
                            </li>
                            <li><strong>Beta-blockers</strong> combine well with:
                                <ul>
                                    <li>Thiazide diuretics</li>
                                    <li>Calcium antagonists (less recommended)</li>
                                    <li>ACE inhibitors (less recommended)</li>
                                    <li>ARBs (less recommended)</li>
                                </ul>
                            </li>
                        </ul>
                        <p><small>Note: Green lines in the original diagram indicate favorable combinations, thin black lines are possible combinations, dashed black lines are less recommended, and thick red lines are not recommended combinations.</small></p>
                    </div>
                </section>
                <!-- END: recommended-combinations -->

                <!-- START: control-issues -->
                <section id="control-issues" class="content-section" aria-labelledby="section-heading-14">
                    <h2 id="section-heading-14" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Control is often poor</span>
                    </h2>
                    <div class="content-card">
                        <h3 class="subsection-heading">Poor compliance</h3>
                        <ul>
                            <li>Denial</li>
                            <li>Inadequate patient education</li>
                            <li>Inadequate life style change</li>
                            <li>Cost</li>
                            <li>Side effects</li>
                            <li>Competing alternative therapies</li>
                            <li>Fatigue</li>
                            <li>Poly pharmacy</li>
                            <li>Poor drug combinations</li>
                            <li>Sub optimal dosing</li>
                        </ul>
                        <h3 class="subsection-heading">Lifestyle Changes are not easy to implement and sustain</h3>
                        <figure>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-37-1.jpg" alt="Photograph of a person eating unhealthy fast food, representing poor dietary lifestyle choices." class="content-image">
                        </figure>
                        <figure>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-38-1.jpg" alt="Photograph of a person smoking a cigarette through a surgical mask, illustrating poor compliance with health advice." class="content-image">
                            <figcaption>HK resident smoking through SARS mask</figcaption>
                        </figure>
                        <figure>
                            <figcaption><strong>Physical (In)Activity</strong></figcaption>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-39-1.jpg" alt="Photograph of people using an escalator next to empty stairs, representing physical inactivity." class="content-image">
                        </figure>
                    </div>
                </section>
                <!-- END: control-issues -->

                <!-- START: culture-of-prevention -->
                <section id="culture-of-prevention" class="content-section" aria-labelledby="section-heading-15">
                    <h2 id="section-heading-15" class="section-heading">
                         <span class="heading-icon"> </span>
                        <span class="heading-text">Towards a Culture of Prevention</span>
                    </h2>
                    <div class="content-card">
                        <figure>
                            <img src="../assets/images/2025_06_29_cac5bcaec1d890075d63g-40-1.jpg" alt="Portrait of Kofi Annan with a quote about prevention being better than reaction." class="content-image">
                            <figcaption>"Today no one disputes that prevention is better and cheaper than reacting to crises after the fact. And yet our political and organizational cultures and practices remain oriented far more towards reaction than prevention." <br> Kofi Annan, September 9, 1999</figcaption>
                        </figure>
                    </div>
                </section>
                <!-- END: culture-of-prevention -->
            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="cardiology-infective-endocarditis-4a.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 34.6%;"></div>
                        </div>
                       <span class="progress-text">Lecture 18 of 52</span>
                    </div>
                    <a href="cardiology-hypertensive-emergencies.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>